Search images on Google Product Monograph
Active Ingredients:
- buserelin (buserelin acetate), 9.45 MG
DIN: 02240749
Dosage Form(s): IMPLANT
Route(s) of Administration: SUBCUTANEOUS
Schedule: Prescription
Company: CHEPLAPHARM ARZNEIMITTEL GMBH
ATC:
- L02 - ENDOCRINE THERAPY (ATC, WHO, Wiki)
- L02A - HORMONES AND RELATED AGENTS (ATC, WHO)
- L02AE - Gonadotropin releasing hormone analogues (ATC, WHO)
- L02AE01 - BUSERELIN (WHO)
Reference brand drug: Suprefact
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 3 IMPLANTS